دورية أكاديمية
639P 223Ra in asymptomatic patients (pts) with metastatic castration-resistant prostate cancer (mCRPC) who progressed to first-line abiraterone acetate or enzalutamide
| العنوان: | 639P 223Ra in asymptomatic patients (pts) with metastatic castration-resistant prostate cancer (mCRPC) who progressed to first-line abiraterone acetate or enzalutamide |
|---|---|
| المؤلفون: | Carles, J., Alonso, T., Mellado Gonzalez, B., Mendez Vidal, M.J., Vazquez Estevez, S., González del Alba, A., Piulats, J.M., Borrega García, P., Gallardo, E., Morales Barrera, R., Paredes, P., Reig, O., Garcías de España, C., Collado, R., Bonfill, T., Suarez, C., Malfettone, A., Garde, J. |
| المصدر: | In Annals of Oncology September 2020 31 Supplement 4:S525-S526 |
| قاعدة البيانات: | ScienceDirect |
كن أول من يترك تعليقا!